Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Medical Genetics

Validation & Orientation: Understanding a Descriptive Diagnosis

At a Glance

Neurodevelopmental delay-intellectual disability-skeletal defects syndrome is often a descriptive label for several rare genetic conditions, not one predictable disease. Identifying the specific gene helps clinicians tailor developmental, skeletal, and family support.

Receiving a diagnosis that sounds like a list of symptoms—Neurodevelopmental delay-intellectual disability-skeletal defects syndrome—can feel overwhelming and clinical [1]. For many parents and caregivers, this moment is the culmination of a long “diagnostic odyssey,” a period of searching for answers that often brings significant emotional strain, caregiving overload, and stress [1][2]. It is normal to feel a mix of relief at finally having a name for the challenges and anxiety about what that name actually means for the future [2].

Understanding a “Descriptive” Diagnosis

In the world of rare genetics, some names are not meant to describe a single disease with a predictable path. Instead, they are descriptive diagnoses—umbrella terms that group individuals together based on shared symptoms while doctors work to find the specific genetic “instruction” that is different [3].

This diagnosis likely falls into this category. It encompasses several ultra-rare disorders caused by changes in different genes, such as:

  • ZTTK Syndrome: Caused by changes in the SON gene.
  • RAUST (Rauch-Steindl Syndrome): A very rare condition involving the NSD2 gene, often characterized by growth failure and delayed bone age [4].
  • IDDOF (MTSS2-related disorder): Specifically involves intellectual disability, ocular (eye) anomalies, and distinctive facial features [5][6].

Because these conditions are “ultra-rare”—sometimes affecting only a few hundred people worldwide—your local doctors may not have seen a case like this before [7]. This does not mean they cannot provide excellent care; it means the management will likely involve a multidisciplinary team, where specialists in genetics, neurology, and orthopedics work together to address unique needs [8][9].

Defining the Core Terms

To advocate effectively, it helps to understand exactly what the medical terms in the diagnosis mean:

  • Neurodevelopmental Disorder (NDD): This is a broad “family” of conditions that affect how the brain develops and functions. It includes a spectrum of conditions from autism and ADHD to more complex syndromes [10][11].
  • Global Developmental Delay (GDD): This term is typically used for younger children when reliable cognitive and adaptive testing is not yet possible. It describes a significant delay in two or more areas, such as walking, talking, or playing [12].
  • Intellectual Disability (ID): This diagnosis requires assessment of both intellectual functioning (learning and problem-solving) and adaptive behavior (everyday social and practical skills) during the developmental period. There is no rigid age cutoff for when this diagnosis can be made [13][14].
  • Skeletal Defects: This refers to differences in how bones or the skeleton are formed. In rare syndromes, this might include things like delayed bone age, vertebral (spine) malformations, or joint differences [4][15].

Navigating Misconceptions about “Delay”

One of the most common misunderstandings is the word “delay.” In everyday language, a delay implies that if you wait long enough or work hard enough, you will “catch up.” In a clinical context, a developmental delay often indicates a different developmental trajectory [16].

While early and ongoing intervention—such as physical, occupational, and speech therapy—can significantly improve skills and quality of life, it does not “erase” the underlying genetic difference [17]. Rather than focusing on “catching up” to a typical milestone chart, care teams focus on helping the individual reach their own personal best [16].

The Power of Rarity

While it can feel isolating to have a condition so rare it lacks a “common” name, you are part of a large global community. Estimates suggest that 3.5% to 5.9% of the world’s population lives with a rare disease, though this estimate varies depending on definitions and data sources [7]. However, remember that being part of the broad rare-disease community does not mean that evidence from unrelated rare disorders applies to this specific syndrome.

Research shows that parents and caregivers who find social support—whether through official foundations or informal online groups—often experience lower levels of parenting stress [18][19]. Connecting with others who understand the “rare life” can provide the practical advice and emotional validation that medical textbooks cannot [20][2].

Common questions in this guide

What does neurodevelopmental delay-intellectual disability-skeletal defects syndrome mean?
It is often a descriptive umbrella label for developmental or intellectual differences occurring with skeletal findings. It may group several rare genetic conditions rather than identify one disease with a single predictable course. The person's specific gene findings and development help guide care.
Does this diagnosis identify the exact genetic condition?
Not necessarily. The label may be used while clinicians work to identify the specific gene or variant, because different genetic conditions can produce similar findings. Ask what gene or variant appears on the report and whether it changes the diagnosis or care plan.
What is the difference between global developmental delay and intellectual disability?
Global developmental delay is usually used in younger children when reliable cognitive and adaptive testing is not yet possible and significant delays are present in two or more areas. Intellectual disability is assessed through intellectual functioning and adaptive behavior, including everyday social and practical skills, during development. A qualified clinician can explain which term fits the individual's current assessment.
Can therapy make the developmental delay go away?
Physical, occupational, and speech therapy can improve skills and quality of life. They do not erase the underlying genetic difference, and progress is better understood through the person's own goals than by expecting them to match a typical milestone chart.
Which specialists may be part of the care team?
Because findings vary, care often involves a multidisciplinary team, meaning several specialties working together. Genetics, neurology, and orthopedics may help evaluate needs and coordinate developmental and skeletal care.
How are skeletal issues monitored as the person grows?
Monitoring is individualized because skeletal findings can differ. Ask the care team how growth, bone age, the spine, and joints will be followed and which changes at home should be reported.
Where can families find support after a rare diagnosis?
Rare-disease foundations and peer groups can provide practical advice and emotional validation from people who understand this experience. Caregivers may also benefit from a support circle and from keeping one central record of test results and specialist notes.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Neurodevelopmental delay-intellectual disability-skeletal defects syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the specific gene or variant name listed on the report, and is this the same as the 'descriptive diagnosis' we were given?
  2. 2.Based on their current development, does the individual meet the criteria for Global Developmental Delay or Intellectual Disability?
  3. 3.Which specialists (such as genetics, orthopedics, or neurology) should be part of our core care team right now?
  4. 4.Are there specific clinical trials or patient registries for this gene that we should know about?
  5. 5.How will we monitor for skeletal issues as they grow, and what should I look for at home?

References

References (20)
  1. 1

    Ultra-rare ultra-care: Assessing the impact of caring for children with ultra rare diseases.

    Domaradzki J, Walkowiak D

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2024; (48()):78-84 doi:10.1016/j.ejpn.2023.12.003.

    PMID: 38071849
  2. 2

    Children with a rare congenital genetic disorder: a systematic review of parent experiences.

    von der Lippe C, Neteland I, Feragen KB

    Orphanet journal of rare diseases 2022; (17(1)):375 doi:10.1186/s13023-022-02525-0.

    PMID: 36253830
  3. 3

    MTSS2 -Related Disorder: Refining the Phenotype in Four New Cases and Literature Review.

    Dominicis A, Sparascio FP, Stregapede F, et al.

    American journal of medical genetics. Part A 2025; (197(6)):e64010 doi:10.1002/ajmg.a.64010.

    PMID: 39890443
  4. 4

    Clinical details of individuals with Rauch-Steindl syndrome due to NSD2 truncating variants.

    Nishi E, Yanagi K, Kaname T, Okamoto N

    Molecular genetics & genomic medicine 2024; (12(2)):e2396 doi:10.1002/mgg3.2396.

    PMID: 38353053
  5. 5

    Identification of a Chinese patient with MTSS2-causing intellectual disability by WES reanalysis: a case report.

    Li D, Zhang W, Mei H, et al.

    Frontiers in psychiatry 2025; (16()):1707837 doi:10.3389/fpsyt.2025.1707837.

    PMID: 41641084
  6. 6

    MTSS2-related neurodevelopmental disorder: Further delineation of the phenotype.

    Corona-Rivera JR, Zenteno JC, Ordoñez-Labastida V, et al.

    European journal of medical genetics 2023; (66(10)):104826 doi:10.1016/j.ejmg.2023.104826.

    PMID: 37657631
  7. 7

    Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database.

    Nguengang Wakap S, Lambert DM, Olry A, et al.

    European journal of human genetics : EJHG 2020; (28(2)):165-173 doi:10.1038/s41431-019-0508-0.

    PMID: 31527858
  8. 8

    Prolonged Follow-Up in a 30-Year-Old Male With a Novel Pathogenic Variant in MSL3 : A Case Report and a Brief Review of the Literature.

    Pisanò G, Cesaroni CA, Rizzi S, et al.

    American journal of medical genetics. Part A 2025; (197(12)):e64196 doi:10.1002/ajmg.a.64196.

    PMID: 40767387
  9. 9

    The clinical and molecular spectrum of the KDM6B-related neurodevelopmental disorder.

    Rots D, Jakub TE, Keung C, et al.

    American journal of human genetics 2023; (110(6)):963-978 doi:10.1016/j.ajhg.2023.04.008.

    PMID: 37196654
  10. 10

    Neurodevelopmental behavioral and cognitive disorders.

    Jeste SS

    Continuum (Minneapolis, Minn.) 2015; (21(3 Behavioral Neurology and Neuropsychiatry)):690-714 doi:10.1212/01.CON.0000466661.89908.3c.

    PMID: 26039849
  11. 11

    Genetic Counseling in Neurodevelopmental Disorders.

    Blesson A, Cohen JS

    Cold Spring Harbor perspectives in medicine 2020; (10(4)) doi:10.1101/cshperspect.a036533.

    PMID: 31501260
  12. 12

    Diagnosis and Management of Global Development Delay: Consensus Guidelines of Growth, Development and Behavioral Pediatrics Chapter, Neurology Chapter and Neurodevelopment Pediatrics Chapter of the Indian Academy of Pediatrics.

    Juneja M, Gupta A, Sairam S, et al.

    Indian pediatrics 2022; (59(5)):401-415.

    PMID: 35188106
  13. 13

    Evaluation of the Child With Developmental Impairments.

    van Karnebeek CDM

    Continuum (Minneapolis, Minn.) 2018; (24(1, Child Neurology)):228-247 doi:10.1212/CON.0000000000000564.

    PMID: 29432245
  14. 14

    Screening, Diagnosis, and Investigation of Global Developmental Delay and Intellectual Developmental Disorder.

    Gouveia Lopes M, Alves AC, Pedrosa I, et al.

    Cureus 2025; (17(12)):e99027 doi:10.7759/cureus.99027.

    PMID: 41527628
  15. 15

    Prenatal prevalence and postnatal manifestations of 16p11.2 deletions: A new insights into neurodevelopmental disorders based on clinical investigations combined with multi-omics analysis.

    Liu L, Wang J, Liu X, et al.

    Clinica chimica acta; international journal of clinical chemistry 2024; (552()):117671 doi:10.1016/j.cca.2023.117671.

    PMID: 37984529
  16. 16

    Does pre-school developmental assessment agree with later intellectual assessment? A retrospective cohort study.

    Karyadiguna N, Bernie C, Barnes EH, et al.

    Journal of paediatrics and child health 2023; (59(8)):962-967 doi:10.1111/jpc.16428.

    PMID: 37226978
  17. 17

    Effectiveness of Early Intervention Programs for Young Children with Global Developmental Delay: A Systematic Review :.

    Almuhanna SM, Alshehri OA, B Alsaadoon BM, et al.

    Galen medical journal 2025; (14()):e3906 doi:10.31661/gmj.vi.3906.

    PMID: 42038902
  18. 18

    Caregiver Burden, Parenting Stress and Coping Strategies: The Experience of Parents of Children and Adolescents with Osteogenesis Imperfecta.

    Aratti A, Zampini L

    Healthcare (Basel, Switzerland) 2024; (12(10)) doi:10.3390/healthcare12101018.

    PMID: 38786428
  19. 19

    Social Media Use Among Parents and Caregivers of Children With Rare Genetic Diseases: Scoping Review.

    Davis C, Bogaert L, Powell J, Low K

    Journal of medical Internet research 2025; (27()):e77087 doi:10.2196/77087.

    PMID: 41313807
  20. 20

    Facebook as a Lifeboat: An Interview Study Exploring the Role of Facebook in Supporting Parents of Children with Rare Diseases.

    Victor B, Yilmaz NG, Hoving C, et al.

    Journal of health communication 2026; 1-13 doi:10.1080/10810730.2026.2723703.

    PMID: 42687858

This page is for informational purposes only and does not constitute medical advice. A genetics, neurology, and orthopedics team should interpret the individual's specific findings and guide care.